- Home
- GNFT vs PSF Comparison
GNFT vs PSF Comparison
Compare GNFT & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- PSF
- Stock Information
- Founded
- GNFT 1999
- PSF 2010
- Country
- GNFT France
- PSF United States
- Employees
- GNFT N/A
- PSF N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- PSF Investment Managers
- Sector
- GNFT Health Care
- PSF Finance
- Exchange
- GNFT Nasdaq
- PSF Nasdaq
- Market Cap
- GNFT 216.7M
- PSF 245.5M
- IPO Year
- GNFT 2019
- PSF N/A
- Fundamental
- Price
- GNFT $4.23
- PSF $20.96
- Analyst Decision
- GNFT Strong Buy
- PSF
- Analyst Count
- GNFT 2
- PSF 0
- Target Price
- GNFT $11.00
- PSF N/A
- AVG Volume (30 Days)
- GNFT 2.8K
- PSF 25.0K
- Earning Date
- GNFT 09-22-2025
- PSF 01-01-0001
- Dividend Yield
- GNFT N/A
- PSF 7.69%
- EPS Growth
- GNFT N/A
- PSF N/A
- EPS
- GNFT 0.03
- PSF N/A
- Revenue
- GNFT $73,187,701.00
- PSF N/A
- Revenue This Year
- GNFT $5.44
- PSF N/A
- Revenue Next Year
- GNFT N/A
- PSF N/A
- P/E Ratio
- GNFT $135.62
- PSF N/A
- Revenue Growth
- GNFT 105.01
- PSF N/A
- 52 Week Low
- GNFT $2.55
- PSF $16.00
- 52 Week High
- GNFT $6.42
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- GNFT 54.29
- PSF 73.93
- Support Level
- GNFT $4.23
- PSF $20.58
- Resistance Level
- GNFT $4.35
- PSF $20.60
- Average True Range (ATR)
- GNFT 0.12
- PSF 0.16
- MACD
- GNFT 0.02
- PSF 0.05
- Stochastic Oscillator
- GNFT 75.35
- PSF 82.97
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.